Suggestions for potential areas of study could come in the form of a retrospective analysis of infection risk in patients with CVID with varying CD4/CD8 ratios as well as analyzing for any potential mortality effects related to CD4/CD8 ratios. This evidence concerns the gene CD4 and common variable immunodeficiency.